390 related articles for article (PubMed ID: 29057544)
21. lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor Signaling Pathway.
Tang XD; Zhang DD; Jia L; Ji W; Zhao YS
Cell Physiol Biochem; 2018; 50(1):179-195. PubMed ID: 30278439
[TBL] [Abstract][Full Text] [Related]
22. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma.
Bo H; Gong Z; Zhang W; Li X; Zeng Y; Liao Q; Chen P; Shi L; Lian Y; Jing Y; Tang K; Li Z; Zhou Y; Zhou M; Xiang B; Li X; Yang J; Xiong W; Li G; Zeng Z
Oncotarget; 2015 Aug; 6(24):20404-18. PubMed ID: 26246469
[TBL] [Abstract][Full Text] [Related]
23. LncRNA SBF2-AS1: A Budding Star in Various Cancers.
Tan F; Chen J; Wang B; Du Z; Mou J; Wu Y; Liu Y; Zhao F; Yuan C
Curr Pharm Des; 2022; 28(18):1513-1522. PubMed ID: 35440300
[TBL] [Abstract][Full Text] [Related]
24. Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association.
El-Sheikh NM; Abulsoud AI; Wasfey EF; Hamdy NM
Pathol Res Pract; 2022 Dec; 240():154183. PubMed ID: 36327824
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer.
Han X; Wang L; Ning Y; Li S; Wang Z
Biol Res; 2016 Aug; 49(1):36. PubMed ID: 27578191
[TBL] [Abstract][Full Text] [Related]
26. Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude mice.
Wu XB; Feng X; Chang QM; Zhang CW; Wang ZF; Liu J; Hu ZQ; Liu JZ; Wu WD; Zhang ZP; Liu XQ
J Exp Clin Cancer Res; 2019 Feb; 38(1):107. PubMed ID: 30819221
[TBL] [Abstract][Full Text] [Related]
27. Expression and functional role of long non-coding RNA AFAP1-AS1 in ovarian cancer.
Yang SL; Lin RX; Si LH; Cui MH; Zhang XW; Fan LM
Eur Rev Med Pharmacol Sci; 2016 Jan; 20(24):5107-5112. PubMed ID: 28051261
[TBL] [Abstract][Full Text] [Related]
28. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
29. Research Progress on Long Non-Coding RNA and Radiotherapy.
Yao Z; Zhang Y; Xu D; Zhou X; Peng P; Pan Z; Xiao N; Yao J; Li Z
Med Sci Monit; 2019 Aug; 25():5757-5770. PubMed ID: 31375656
[TBL] [Abstract][Full Text] [Related]
30. AFAP1-AS1 is upregulated and promotes esophageal squamous cell carcinoma cell proliferation and inhibits cell apoptosis.
Luo HL; Huang MD; Guo JN; Fan RH; Xia XT; He JD; Chen XF
Cancer Med; 2016 Oct; 5(10):2879-2885. PubMed ID: 27577754
[TBL] [Abstract][Full Text] [Related]
31. The clinical significance and biological function of lncRNA RGMB-AS1 in hepatocellular carcinoma.
Sheng N; Li Y; Qian R; Li Y
Biomed Pharmacother; 2018 Feb; 98():577-584. PubMed ID: 29288973
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.
Lian Y; Xiong F; Yang L; Bo H; Gong Z; Wang Y; Wei F; Tang Y; Li X; Liao Q; Wang H; Zhou M; Xiang B; Wu X; Li Y; Li X; Chen X; Li G; Guo C; Zeng Z; Xiong W
J Exp Clin Cancer Res; 2018 Oct; 37(1):253. PubMed ID: 30326930
[TBL] [Abstract][Full Text] [Related]
33. ZEB1-AS1: A crucial cancer-related long non-coding RNA.
Li J; Li Z; Leng K; Xu Y; Ji D; Huang L; Cui Y; Jiang X
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226522
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA AFAP1-AS1 accelerates the proliferation and metastasis of prostate cancer via inhibiting RBM5 expression.
Yang ZT; An F; Hu JD; Zhao WH
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3284-3290. PubMed ID: 31081081
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding PANDAR as a novel biomarker in human cancer: A systematic review.
Zou Y; Zhong Y; Wu J; Xiao H; Zhang X; Liao X; Li J; Mao X; Liu Y; Zhang F
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226461
[TBL] [Abstract][Full Text] [Related]
36. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA CASC2 regulates cell biological behaviour through the MAPK signalling pathway in hepatocellular carcinoma.
Gan Y; Han N; He X; Yu J; Zhang M; Zhou Y; Liang H; Deng J; Zheng Y; Ge W; Long Z; Xu X
Tumour Biol; 2017 Jun; 39(6):1010428317706229. PubMed ID: 28621238
[TBL] [Abstract][Full Text] [Related]
38. CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.
Xin Y; Li Z; Shen J; Chan MT; Wu WK
Cell Prolif; 2016 Jun; 49(3):255-60. PubMed ID: 27134049
[TBL] [Abstract][Full Text] [Related]
39. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
Wei C; Wang H; Xu F; Liu Z; Jiang R
Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway.
Guo JQ; Li SJ; Guo GX
Dig Dis Sci; 2017 Aug; 62(8):2004-2010. PubMed ID: 28451917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
